HumanCo Upsizes IPO to $250M

Focused on the healthy living space, the SPAC registered an additional 2.5 million units to raise the IPO to $250 million from the initial registration of $225 million.

Sponsor HumanCo Acquisition Holdings has agreed to purchase warrants up to $7.5 million in a private placement that will close concurrently with the IPO. CAVU Venture Partners III, a member of the sponsor, has agreed to purchase units for up to $25 million in a private placement. 

The SPAC will trade on the Nasdaq under HMCOU. Read more.

Total
0
Shares
Related Posts